藥明康德遭美國國防部移出中國軍事企業名單

華盛頓，11月9日（路透）——根據週一的一份政府公告，美國國防部（Pentagon）已將中國生技公司藥明康德（WuXi AppTec）從中國軍事企業名單中移除。WASHINGTON, Nov 9 (Reuters) - The Pentagon removed Chinese biotechnology company WuXi AppTec from its list of Chinese military companies, according to a government posting on Monday.

公告稱，鑑於華盛頓一所聯邦法院禁止國防部執行這項列名認定，副國防部長作出這項決定。The deputy secretary of defense made the determination in light of a federal court in Washington barring the department from enforcing the designation, the posting said.

這項裁定源於藥明康德在被美國國防部列入名單後提起的訴訟。藥明康德表示，將其列名的決定武斷、反覆無常、缺乏事實支持，且是「政治壓力的產物」。The ruling came in a lawsuit WuXi AppTec filed after the Pentagon added it to the list, saying its designation was arbitrary, capricious, unsupported by the facts and "the product of political pressure."

美國國防部6月8日擴大其所謂「中國軍事企業」黑名單，將名單增至188個實體。The Pentagon expanded its blacklist of alleged "Chinese military companies" on June 8 to 188 entities.

藥明康德週二上午向香港交易所提交的文件中表示：「這項決定使公司免於1260H列名認定所帶來的進一步不利後果。」該公司指的是依據美國一項國防法律第1260H條維持的這份名單。"This decision relieves the company from further adverse consequences of the 1260H designation," WuXi AppTec said in a filing to the Hong Kong bourse on Tuesday morning, referring to the list which is kept under Section 1260H of a US defense law.

該公司並表示：「我們仍致力於服務客戶，協助他們為患者製造能夠拯救生命、改善生命的藥物。」"We remain committed to serving our customers and enabling the lifesaving and life-improving medicines they make for patients," the company added.

（紐約Karen Freifeld、華盛頓Kat Jackson採訪報導；Doina Chiacu與Matthew Lewis編輯）(Reporting by Karen Freifeld in New York and Kat Jackson in Washington; Editing by Doina Chiacu and Matthew Lewis)